Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.
Rac1 is a ubiquitously expressed Rho GTPase and an important regulator of the actin cy-toskeleton. Its splice variant Rac1b exhibits a 19aa in-frame insertion and is predominantly active. Both proteins were described in tumorigenesis or metastasis. We investigated the contribution of Rac1 and Rac1b to tumor progression of human non-small-cell-lungadenocarcinoma (NSCLA). Rac1 protein was present in 8/8 NSCLA cell lines analyzed, whereas Rac1b was expressed in only 6/8. In wound healing assays, EGFP-Rac1 slightly de-creased cell migration, whereas proliferation was increased in both, Rac1- and Rac1bexpressing cells. In the in vivo chorioallantoic invasion model, EGFP-Rac1-expressing cells formed more invasive tumors compared to EGFP-Rac1b. This increased invasiveness correlated with enhanced phosphorylation of p38α, AKT, and GSK3β and activation of serum response- and Smad-dependent gene promoters by Rac1. In contrast, Rac1b solely activated the MAP kinase JNK2, together with TCF/LEF1- and NFκB-responsive gene reporters. Rac1b, as Rac1 phosphorylated p38α, AKT, and GSK3β. Knockdown of the splicing factor ESRP1, which mediates out-splicing of exon 3b from RAC1, resulted in increased Rac1b mRNA and suppression of the EMT-associated transcription factor ZEB1. Our data demonstrate different signaling and functional activities of Rac1 and Rac1b and an important role for Rac1 in lung cancer metastasis.